Philips delivered good order book growth and announced an agreement with the US Department of Justice regarding the Respironics recall. The focus on profitability lifted operating margin. Shares were up modestly on the news.
Philips is the first to market with its helium-free 3.0T MR, which should help it recover some market share losses following its supply chain issues.
China's return to prominence is highly uncertain. Philips has an outsize exposure to this market, both in imaging and personal health.
Metric | PHIA | RMD | SHL |
|---|---|---|---|
Price/Earnings (Normalized) | 15.05 | 20.94 | 19.91 |
Price/Book Value | 2.30 | 5.78 | 2.48 |
Price/Sales | 1.51 | 6.11 | 2.09 |
Price/Cash Flow | 11.67 | 18.60 | 16.41 |
Metric | PHIA | RMD | SHL |
|---|---|---|---|
Quick Ratio | 0.81 | 1.54 | 0.78 |
Current Ratio | 1.33 | 2.65 | 1.18 |
Interest Coverage | 4.87 | — | 7.80 |
Metric | PHIA | RMD | SHL |
|---|---|---|---|
Return on Assets (Normalized) | 6.21% | 19.58% | 4.97% |
Return on Equity (Normalized) | 14.95% | 26.61% | 11.98% |
Return on Invested Capital (Normalized) | 9.49% | 22.99% | 12.63% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|Dc@k?sQ | LOCK|J^H< | $188B | |||
| Medtronic PLC MDT | LOCK|#^k@p@ | LOCK|!b!%l | $132B | |||
| Stryker Corp SYK | LOCK|cZV>F$W | LOCK|?S | $118B | |||
| Boston Scientific Corp BSX | LOCK|T$?^^% | LOCK|L^xQ | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|SzqpW@WF | LOCK|zVh< | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|?nG<b?R | LOCK|?Dn | $38B | |||
| DexCom Inc DXCM | LOCK|Hkx>hX^ | LOCK|xnz? | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|w!r | LOCK|Yx | $30B | |||
| Steris PLC STE | LOCK|mXDp>m | LOCK|H!^k% | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|NwHJ?QzP | LOCK|#R | $20B |
United States